Finance

Lists
300016:SHE
Beijing Beilu Pharmaceutical Co Ltd
CNÂ¥8.00
+1.91%
(+0.15) 1D
Nov 4, 3:04:43 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300016...
Open
CNÂ¥7.80
High
CNÂ¥8.00
Low
CNÂ¥7.63
Mkt. cap
4.57B
Avg. vol.
33.01M
Volume
31.91M
Dividend
0.75%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Sep 23, 2026
P/E ratio
27.88
52-wk high
CNÂ¥11.38
52-wk low
CNÂ¥7.08
EPS
CNÂ¥0.29
Shares outstanding
581.69M
No. of employees
1K
Open
CNÂ¥7.80
High
CNÂ¥8.00
Low
CNÂ¥7.63
Mkt. cap
4.57B
Avg. vol.
33.01M
Volume
31.91M
Dividend
0.75%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Sep 23, 2026
P/E ratio
27.88
52-wk high
CNÂ¥11.38
52-wk low
CNÂ¥7.08
EPS
CNÂ¥0.29
Shares outstanding
581.69M
No. of employees
1K
News stories
From web sources and news partners
About Beijing Beilu Pharmaceutical Co Ltd
CEO-
Employees1.19K
FoundedSep 5, 1992
Headquarters-
SectorPharmaceutical industry
Industry-
Websitebeilu.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
332.59M
320.37M
352.96M
385.23M
Cost of goods sold
189.95M
171.34M
209.05M
242.14M
Cost of revenue
189.95M
171.34M
209.05M
242.14M
Research and development expenses
29.43M
15.45M
14.76M
11.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97.35M
84.08M
78.55M
79.27M
Operating expense
130.35M
98.63M
94.66M
92.67M
Total operating expenses
320.30M
269.97M
303.71M
334.81M
Operating income
12.29M
50.40M
49.25M
50.42M
Other non operating income
1.55M
-3.19M
3.18M
-17.65M
EBT including unusual items
63.53M
54.70M
46.34M
38.27M
EBT excluding unusual items
10.67M
50.52M
48.04M
46.13M
Income tax expense
14.35M
8.54M
7.32M
2.07M
Effective tax rate
22.58%
15.62%
15.80%
5.40%
Other operating expenses
1.18M
97.64K
1.21M
591.36K
Net income
48.56M
44.98M
34.78M
34.15M
Net profit margin
14.60%
14.04%
9.85%
8.86%
Earnings per share
-
-
-
-
Interest and investment income
2.45M
6.71M
5.28M
7.09M
Interest expense
-2.58M
-3.39M
-3.40M
-
Net interest expenses
-136.14K
3.31M
1.88M
7.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
36.01M
74.12M
73.80M
74.14M
Gain or loss from assets sale
1.23M
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps